Kbc Group Nv Biomarin Pharmaceutical Inc Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Kbc Group Nv holds 126,417 shares of BMRN stock, worth $6.92 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

126,417

Previous 125,300 0.89%

Holding current value

$6.92 Million

Previous $8.86 Million 21.54%

% of portfolio

0.02%

Previous 0.03%

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$54.08 - $68.32 $60,407 - $76,313	1,117 Added 0.89%	126,417 $6.95 Million
Q1 2025 Apr 25, 2025	SELL	$61.25 - $72.83 $330,627 - $393,136	-5,398 Reduced 4.13%	125,300 $8.86 Million
Q4 2024 Jan 22, 2025	SELL	$61.93 - $70.49 $2.06 Million - $2.34 Million	-33,249 Reduced 20.28%	130,698 $8.59 Million
Q3 2024 Nov 06, 2024	SELL	$69.02 - $93.84 $4.71 Million - $6.41 Million	-68,308 Reduced 29.41%	163,947 $11.5 Million
Q2 2024 Jul 17, 2024	BUY	$74.43 - $92.22 $168,509 - $208,786	2,264 Added 0.98%	232,255 $19.1 Million

Q1 2024 May 08, 2024	SELL	$83.81 - $99.0 $1.01 Million - $1.2 Million	-12,109 Reduced 5.0%	229,991 $20.1 Million
Q4 2023 Feb 13, 2024	SELL	$76.22 - $98.51 $3.26 Million - $4.22 Million	-42,801 Reduced 15.02%	242,100 $23.3 Million
Q3 2023 Feb 15, 2024	SELL	$85.07 - $94.48 $3.17 Million - $3.52 Million	-37,208 Reduced 12.95%	250,022 $22.1 Million
Q2 2023 Feb 15, 2024	BUY	$86.68 - $100.3 $5.21 Million - $6.03 Million	60,090 Added 26.46%	287,230 $24.9 Million
Q2 2023 Jul 28, 2023	BUY	$86.68 - $100.3 $582,749 - $674,316	6,723 Added 2.42%	284,901 $24.7 Million
Q1 2023 Feb 14, 2024	SELL	$87.74 - $117.27 $3.69 Million - $4.93 Million	-42,036 Reduced 13.07%	279,664 $27.2 Million
Q1 2023 May 04, 2023	BUY	$87.74 - $117.27 $4.49 Million - $6.01 Million	51,215 Added 22.57%	278,178 $27.1 Million
Q4 2022 Feb 14, 2024	BUY	$80.93 - $108.63 $7.6 Million - $10.2 Million	93,860 Added 41.2%	321,700 $33.3 Million
Q3 2022 Feb 15, 2024	SELL	$82.16 - $96.94 $1.23 Million - $1.45 Million	-14,960 Reduced 6.18%	227,140 $19.3 Million
Q3 2022 Nov 08, 2022	SELL	$82.16 - $96.94 $72,054 - $85,016	-877 Reduced 0.38%	226,963 $19.2 Million
Q2 2022 Feb 14, 2024	BUY	$71.48 - $86.85 $3.11 Million - $3.78 Million	43,486 Added 23.59%	227,840 $18.9 Million
Q2 2022 Jul 26, 2022	BUY	$71.48 - $86.85 $3.11 Million - $3.78 Million	43,486 Added 23.59%	227,840 $18.9 Million
Q1 2022 Feb 14, 2024	SELL	$74.28 - $92.69 $605,456 - $755,516	-8,151 Reduced 4.23%	184,354 $14.2 Million
Q1 2022 May 06, 2022	SELL	$74.28 - $92.69 $605,456 - $755,516	-8,151 Reduced 4.23%	184,354 $14.2 Million
Q4 2021 Feb 14, 2024	SELL	$71.72 - $91.47 $3.56 Million - $4.54 Million	-49,595 Reduced 20.49%	192,505 $17 Million
Q4 2021 Feb 03, 2022	SELL	$71.72 - $91.47 $9.69 Million - $12.4 Million	-135,059 Reduced 41.23%	192,505 $17 Million
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $7.02 Million - $8.02 Million	93,826 Added 40.14%	327,564 $25.3 Million
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $3.71 Million - $4.16 Million	49,110 Added 26.6%	233,738 $19.5 Million
Q1 2021 Apr 26, 2021	BUY	$74.73 - $90.69 $3.03 Million - $3.67 Million	40,507 Added 28.11%	184,628 $13.9 Million
Q4 2020 Feb 10, 2021	SELL	$72.61 - $90.2 $4.12 Million - $5.12 Million	-56,718 Reduced 28.24%	144,121 $12.6 Million
Q3 2020 Oct 28, 2020	BUY	$71.87 - $131.03 $722,437 - $1.32 Million	10,052 Added 5.27%	200,839 $15.3 Million
Q2 2020 Aug 10, 2020	BUY	$79.55 - $124.22 $7.44 Million - $11.6 Million	93,483 Added 96.07%	190,787 $23.5 Million
Q1 2020 May 04, 2020	SELL	$71.37 - $96.85 $4.46 Million - $6.05 Million	-62,427 Reduced 39.08%	97,304 $8.22 Million
Q4 2019 Feb 11, 2020	BUY	$64.27 - $86.37 $815,907 - $1.1 Million	12,695 Added 8.63%	159,731 $13.5 Million
Q3 2019 Nov 07, 2019	BUY	$67.4 - $85.11 $1.83 Million - $2.31 Million	27,083 Added 22.58%	147,036 $9.91 Million
Q2 2019 Jul 30, 2019	BUY	$80.35 - $93.9 $1.35 Million - $1.58 Million	16,852 Added 16.35%	119,953 $0
Q1 2019 May 10, 2019	SELL	$84.2 - $98.62 $370,648 - $434,125	-4,402 Reduced 4.09%	103,101 $0
Q4 2018 Jan 31, 2019	SELL	$80.14 - $106.07 $2.79 Million - $3.69 Million	-34,780 Reduced 24.44%	107,503 $9.15 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $9.49 Million - $10.7 Million	101,089 Added 245.4%	142,283 $0
Q2 2018 Aug 03, 2018	SELL	$76.01 - $99.03 $17.7 Million - $23.1 Million	-233,204 Reduced 84.99%	41,194 $0
Q1 2018 May 09, 2018	SELL	$77.67 - $92.63 $3.1 Million - $3.69 Million	-39,873 Reduced 12.69%	274,398 $0
Q4 2017 Feb 07, 2018	SELL	$80.76 - $95.13 $4.25 Million - $5 Million	-52,601 Reduced 14.34%	314,271 $0
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $29.6 Million - $34.8 Million	366,872	366,872 $0

Others Institutions Holding BMRN

# of Institutions

667

Shares Held

182M

Call Options Held

1.48M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account